Tearsheet

Owens & Minor (OMI)

Market Price (10/17/2025): $4.58 | Market Cap: $352.4 Mil
Sector: Health Care | Industry: Health Care Distributors

Owens & Minor (OMI)

Market Price (10/17/2025): $4.58
Market Cap: $352.4 Mil
Sector: Health Care
Industry: Health Care Distributors

Investment Highlights

0	Valuation becoming less expensive P/S 6M Chg %Price/Sales change over 6 months. Declining P/S indicates valuation has become less expensive. is -31%	Weak multi-year price returns 2Y Excs Rtn is -122%, 3Y Excs Rtn is -165%	Debt is significant Net D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is 572%
1		Meaningful short interest Short Interest % of Basic SharesShort Interest % of Basic Shares = (Short Interest Quantity) / (Basic Shares Outstanding). A high fraction of short interest can indicate potential risk of a short squeeze. is 10%	Weak revenue growth Rev Chg 3Y AvgRevenue Change % averaged over trailing 3 years is -3.6%
2			Not cash flow generative FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is -1.9%
3			Yield minus risk free rate is negative ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -345%

0	Valuation becoming less expensive P/S 6M Chg %Price/Sales change over 6 months. Declining P/S indicates valuation has become less expensive. is -31%
1	Weak multi-year price returns 2Y Excs Rtn is -122%, 3Y Excs Rtn is -165%
2	Meaningful short interest Short Interest % of Basic SharesShort Interest % of Basic Shares = (Short Interest Quantity) / (Basic Shares Outstanding). A high fraction of short interest can indicate potential risk of a short squeeze. is 10%
3	Debt is significant Net D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is 572%
4	Weak revenue growth Rev Chg 3Y AvgRevenue Change % averaged over trailing 3 years is -3.6%
5	Not cash flow generative FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is -1.9%
6	Yield minus risk free rate is negative ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -345%

Market Valuation & Key Metrics

Valuation
Key Metrics

	10/17/25	2024	2023	2022	2021
Share Price CYE	$4.58	$13.07	$19.27	$19.53	$43.50
Market Cap CYE ($ Mil)	352.4	1,006.3	1,465.8	1,461.9	3,176.8
Total Debt ($ Mil)	2,058.7	2,139.8	2,319.9	2,716.3	1,109.8
Total Cash ($ Mil)	38.3	49.4	243.0	69.5	55.7
Enterprise Value ($ Mil)	2,372.8	3,146.1	3,785.7	4,178.2	4,286.6
Valuation Ratios
P/S TTM	0.0	0.1	0.1	0.1	0.3
P/EBIT TTM	-1.2	-4.7	14.2	10.4	9.7
P/E TTM	-0.3	-2.8	-35.4	65.0	14.3
Sector Ratios
P/S TTM (Sector)	4.1	3.5	4.1	4.6	7.4
P/EBIT TTM (Sector)	-1.8	-1.3	-1.4	-1.3	-2.7
P/E TTM (Sector)	-2.1	-1.6	-1.5	-1.3	-2.8

	10/17/25	2024	2023
Share Price CYE	$4.58	$13.07	$19.27
Market Cap CYE ($ Mil)	352.4	1,006.3	1,465.8
Total Debt ($ Mil)	2,058.7	2,139.8	2,319.9
Total Cash ($ Mil)	38.3	49.4	243.0
Enterprise Value ($ Mil)	2,372.8	3,146.1	3,785.7
Valuation Ratios
P/S TTM	0.0	0.1	0.1
P/EBIT TTM	-1.2	-4.7	14.2
P/E TTM	-0.3	-2.8	-35.4
Sector Ratios
P/S TTM (Sector)	4.1	3.5	4.1
P/EBIT TTM (Sector)	-1.8	-1.3	-1.4
P/E TTM (Sector)	-2.1	-1.6	-1.5

	OMI	S&P 500
REVENUE GROWTH
Rev LTM ($ Bil)	8.7
Rev Chg Q	3.3%	6.2%
Rev Chg LTM	2.5%	5.2%
Rev Chg 3Y Avg	-3.6%	5.4%
PROFITABILITY	VERY POOR
Op Inc LTM ($ Bil)	0.3
Op Mgn LTM	3.3%	18.6%
CFO LTM ($ Bil)	0.1
CFO/Rev LTM	1.2%	20.3%
Net Inc LTM ($ Bil)	-1.2
Net Inc Mgn	-13.8%	12.7%
VALUATION	VERY LOW
P/S	0.0	3.3
P/CFO	3.5	15.9
P/FCF	-2.1	20.8
P/E	-0.3	24.0
STABILITY	VERY POOR
Debt/Equity	5.84	0.21
Cash/Assets	0.01	0.07

OMI Stock

Return (1M):

Return vs. Risk

Price Returns Compared

	2020	2021	2022	2023	2024	2025	Total [1]
Returns
OMI Return	424%	61%	-55%	-1%	-32%	-65%	-13%
Peers Return	11%	20%	27%	16%	9%	20%	155%
S&P 500 Return	16%	27%	-19%	24%	23%	13%	103%
Monthly Win Rates [3]
OMI Win Rate	83%	67%	25%	42%	50%	22%
Peers Win Rate	40%	45%	50%	50%	45%	53%
S&P 500 Win Rate	58%	75%	42%	67%	75%	67%
Max Drawdowns [4]
OMI Max Drawdown	-20%	-6%	-65%	-38%	-39%	-65%
Peers Max Drawdown	-17%	-5%	-4%	-11%	-4%	-2%
S&P 500 Max Drawdown	-31%	-1%	-25%	-1%	-2%	-15%

[1] Cumulative total returns since the beginning of 2020
[2] Peers: MCK, CAH, HSIC, EMPG, COR. See OMI Returns vs. Peers.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2025 data is for the year up to 10/16/2025 (YTD)

Downturns Compared

Unique Key	Event	OMI	S&P 500
2022 Inflation Shock	2022 Inflation Shock
2022 Inflation Shock% Loss	% Loss	-75.1%	-25.4%
2022 Inflation Shock% Gain to Breakeven	% Gain to Breakeven	302.3%	34.1%
2022 Inflation ShockTime to Breakeven	Time to Breakeven	Not Fully Recovered days	464 days
2020 Covid Pandemic	2020 Covid Pandemic
2020 Covid Pandemic% Loss	% Loss	-42.7%	-33.9%
2020 Covid Pandemic% Gain to Breakeven	% Gain to Breakeven	74.5%	51.3%
2020 Covid PandemicTime to Breakeven	Time to Breakeven	18 days	148 days
2018 Correction	2018 Correction
2018 Correction% Loss	% Loss	-93.3%	-19.8%
2018 Correction% Gain to Breakeven	% Gain to Breakeven	1396.0%	24.7%
2018 CorrectionTime to Breakeven	Time to Breakeven	604 days	120 days
2008 Global Financial Crisis	2008 Global Financial Crisis
2008 Global Financial Crisis% Loss	% Loss	-37.8%	-56.8%
2008 Global Financial Crisis% Gain to Breakeven	% Gain to Breakeven	60.7%	131.3%
2008 Global Financial CrisisTime to Breakeven	Time to Breakeven	756 days	1480 days

How Low Can It Go?

Owens & Minor's stock fell -75.1% during the 2022 Inflation Shock from a high on 6/8/2021. A -75.1% loss requires a 302.3% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth over time.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

Better Bets than Owens & Minor (OMI)

	OMI	Better Performance than OMI
Metric	Value	Industry (Health Care Distributors)
Rev Chg LTM	2.5%	MCK (20.3%), COR (11.6%)
Rev Chg 3Y Avg	-3.6%	MCK (12.2%), COR (10.3%), CAH (7.3%), HSIC (0.2%), QIPT (24.7%)
Op Mgn LTM	3.3%	HSIC (6.0%), SNYR (17.7%)
CFO/Rev LTM	1.2%	MCK (1.7%), HSIC (4.0%), QIPT (15.9%)
FCF/Rev LTM	-1.9%	MCK (1.5%), COR (0.4%), CAH (0.8%), HSIC (2.6%), QIPT (10.0%)
Total Yield	-340.6%	MCK (3.6%), COR (3.8%), CAH (5.6%), HSIC (5.1%), QIPT (-9.5%)

	OMI	Better Performance than OMI
Metric	Value	Sector (Health Care)
Rev Chg LTM	2.5%	LLY (36.8%), JNJ (4.7%), ABBV (6.1%), UNH (9.7%), ABT (5.9%)
Rev Chg 3Y Avg	-3.6%	LLY (23.4%), JNJ (4.0%), ABBV (0.6%), UNH (11.3%), ABT (-1.5%)
Op Mgn LTM	3.3%	LLY (43.0%), JNJ (24.5%), ABBV (23.5%), UNH (7.3%), ABT (17.4%)
CFO/Rev LTM	1.2%	LLY (20.5%), JNJ (25.4%), ABBV (33.1%), UNH (6.8%), ABT (21.0%)
FCF/Rev LTM	-1.9%	LLY (-0.1%), JNJ (18.1%), ABBV (31.3%), UNH (6.0%), ABT (15.7%)
Total Yield	-340.6%	LLY (2.6%), JNJ (7.5%), ABBV (3.8%), UNH (9.0%), ABT (8.1%)

	OMI	Better Performance than OMI
Metric	Value	All Other Sectors
Rev Chg LTM	2.5%	NVDA (71.6%), MSFT (14.9%), AAPL (6.0%), GOOGL (13.1%), AMZN (10.9%)
Rev Chg 3Y Avg	-3.6%	NVDA (92.0%), MSFT (12.5%), AAPL (1.8%), GOOGL (10.2%), AMZN (11.3%)
Op Mgn LTM	3.3%	NVDA (58.1%), MSFT (45.6%), AAPL (31.9%), GOOGL (32.7%), AMZN (11.4%)
CFO/Rev LTM	1.2%	NVDA (46.6%), MSFT (48.3%), AAPL (26.6%), GOOGL (36.0%), AMZN (18.1%)
FCF/Rev LTM	-1.9%	NVDA (43.6%), MSFT (25.4%), AAPL (23.5%), GOOGL (18.0%), AMZN (2.0%)
Total Yield	-340.6%	NVDA (2.0%), MSFT (3.3%), AAPL (3.1%), GOOGL (4.1%), AMZN (3.1%)

Latest Trefis Analyses

	Title	Topic	Date
0	DASHBOARDS
1	Day 5 of Loss Streak for Owens & Minor Stock with -11% Return (vs. -61% YTD) [8/22/2025]	Notification
2	Owens & Minor (OMI) Operating Cash Flow Comparison	Financials
3	Owens & Minor (OMI) Operating Income Comparison	Financials
4	Owens & Minor (OMI) Net Income Comparison	Financials
5	Owens & Minor (OMI) Debt Comparison	Financials
6	Owens & Minor (OMI) EBITDA Comparison	Financials
7	Owens & Minor (OMI) Tax Expense Comparison	Financials
8	Owens & Minor (OMI) Revenue Comparison	Financials
9	OMI Dip Buy Analysis
10	Owens & Minor Total Shareholder Return (TSR): -32.2% in 2024 and -33.0% 3-yr compounded annual returns (below peer average)
11	ARTICLES
12	OMI Stock Down -11% after 5-Day Loss Streak		August 22nd, 2025
13	Market Movers \| Winners: TLRY, TGNA, MLNK \| Losers: OMI, AI, MAX		August 12th, 2025
14	OMI Stock Up 29% after 6-Day Win Streak		July 2nd, 2025
15	Is There A Better Pick Over Owens & Minor Stock?		March 18th, 2022
16	Is A Fall Imminent In Owens & Minor Stock After A Large 38% Rise In A Month?		November 9th, 2021

	Title
0	DASHBOARDS
1	OMI Stock Down -11% after 5-Day Loss Streak
2	Market Movers \| Winners: TLRY, TGNA, MLNK \| Losers: OMI, AI, MAX
3	OMI Stock Up 29% after 6-Day Win Streak
4	Is There A Better Pick Over Owens & Minor Stock?
5	Is A Fall Imminent In Owens & Minor Stock After A Large 38% Rise In A Month?
6	ARTICLES
7	Day 5 of Loss Streak for Owens & Minor Stock with -11% Return (vs. -61% YTD) [8/22/2025]
8	Owens & Minor (OMI) Operating Cash Flow Comparison
9	Owens & Minor (OMI) Operating Income Comparison
10	Owens & Minor (OMI) Net Income Comparison
11	Owens & Minor (OMI) Debt Comparison
12	Owens & Minor (OMI) EBITDA Comparison
13	Owens & Minor (OMI) Tax Expense Comparison
14	Owens & Minor (OMI) Revenue Comparison
15	OMI Dip Buy Analysis
16	Owens & Minor Total Shareholder Return (TSR): -32.2% in 2024 and -33.0% 3-yr compounded annual returns (below peer average)

Trade Ideas

Select past ideas related to OMI. For more, see Trefis Trade Ideas.

Unique Key	Date	Ticker	Company	Category	Trade Strategy	6M Fwd Rtn	12M Fwd Rtn	12M Max DD
ADMA_9302025_Dip_Buyer_ValueBuy	09302025	ADMA	ADMA Biologics	Dip Buy	DB \| P/E OPMDip Buy with Low PE and High Margin Buying dips for companies with tame PE and meaningfully high operating margin	-0.7%	-0.7%	-4.6%
REGN_9302025_Dip_Buyer_ValueBuy	09302025	REGN	Regeneron Pharmaceuticals	Dip Buy	DB \| P/E OPMDip Buy with Low PE and High Margin Buying dips for companies with tame PE and meaningfully high operating margin	1.2%	1.2%	-0.8%
HAE_9262025_Dip_Buyer_High_FCF_Yield_ExInd_DE_RevG	09262025	HAE	Haemonetics	Dip Buy	DB \| FCF Yield \| Low D/EDip Buy with High Free Cash Flow Yield Buying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap	3.3%	3.3%	-0.1%
WAT_9192025_Monopoly_xInd_xCD_Getting_Cheaper	09192025	WAT	Waters	Monopoly	MY \| Getting CheaperMonopoly-Like with P/S Decline Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple	11.3%	11.3%	-4.3%
ISRG_9052025_Monopoly_xInd_xCD_Getting_Cheaper	09052025	ISRG	Intuitive Surgical	Monopoly	MY \| Getting CheaperMonopoly-Like with P/S Decline Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple	-6.9%	-6.9%	-8.0%
OMI_6302024_Dip_Buyer_High_FCF_Yield_ExInd_DE_RevG	06302024	OMI	Owens & Minor	Dip Buy	DB \| FCF Yield \| Low D/EDip Buy with High Free Cash Flow Yield Buying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap	-4.1%	-32.6%	-53.9%
OMI_3312023_Dip_Buyer_High_FCF_Yield_ExInd_DE_RevG	03312023	OMI	Owens & Minor	Dip Buy	DB \| FCF Yield \| Low D/EDip Buy with High Free Cash Flow Yield Buying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap	11.1%	90.4%	-6.9%
OMI_9302022_Dip_Buyer_High_FCF_Yield_ExInd_DE_RevG	09302022	OMI	Owens & Minor	Dip Buy	DB \| FCF Yield \| Low D/EDip Buy with High Free Cash Flow Yield Buying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap	-39.6%	-32.9%	-49.8%

Unique Key	Date	Ticker	Company	Category	Trade Strategy	6M Fwd Rtn	12M Fwd Rtn	12M Max DD
ADMA_9302025_Dip_Buyer_ValueBuy	09302025	ADMA	ADMA Biologics	Dip Buy	DB \| P/E OPMDip Buy with Low PE and High Margin Buying dips for companies with tame PE and meaningfully high operating margin	-0.7%	-0.7%	-4.6%
REGN_9302025_Dip_Buyer_ValueBuy	09302025	REGN	Regeneron Pharmaceuticals	Dip Buy	DB \| P/E OPMDip Buy with Low PE and High Margin Buying dips for companies with tame PE and meaningfully high operating margin	1.2%	1.2%	-0.8%
HAE_9262025_Dip_Buyer_High_FCF_Yield_ExInd_DE_RevG	09262025	HAE	Haemonetics	Dip Buy	DB \| FCF Yield \| Low D/EDip Buy with High Free Cash Flow Yield Buying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap	3.3%	3.3%	-0.1%
WAT_9192025_Monopoly_xInd_xCD_Getting_Cheaper	09192025	WAT	Waters	Monopoly	MY \| Getting CheaperMonopoly-Like with P/S Decline Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple	11.3%	11.3%	-4.3%
ISRG_9052025_Monopoly_xInd_xCD_Getting_Cheaper	09052025	ISRG	Intuitive Surgical	Monopoly	MY \| Getting CheaperMonopoly-Like with P/S Decline Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple	-6.9%	-6.9%	-8.0%
OMI_6302024_Dip_Buyer_High_FCF_Yield_ExInd_DE_RevG	06302024	OMI	Owens & Minor	Dip Buy	DB \| FCF Yield \| Low D/EDip Buy with High Free Cash Flow Yield Buying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap	-4.1%	-32.6%	-53.9%
OMI_3312023_Dip_Buyer_High_FCF_Yield_ExInd_DE_RevG	03312023	OMI	Owens & Minor	Dip Buy	DB \| FCF Yield \| Low D/EDip Buy with High Free Cash Flow Yield Buying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap	11.1%	90.4%	-6.9%
OMI_9302022_Dip_Buyer_High_FCF_Yield_ExInd_DE_RevG	09302022	OMI	Owens & Minor	Dip Buy	DB \| FCF Yield \| Low D/EDip Buy with High Free Cash Flow Yield Buying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap	-39.6%	-32.9%	-49.8%

Recent Active Movers

1 Day Top Gainers

#	Ticker	Company	1D Rtn	YTD Rtn
1	PRAX	Praxis Precision Medicines	183.7%	111.4%
2	JBHT	JB Hunt Transport Services	22.1%	0.3%
3	PSNL	Personalis	20.5%	77.9%
4	GRAL	GRAIL	14.4%	384.1%
5	GTLB	GitLab	10.6%	-14.3%
6	KYIV	Kyivstar	9.3%
7	HL	Hecla Mining	7.6%	211.0%
8	TFIN	Triumph Financial	7.1%	-43.6%
9	TFII	TFI International	7.1%	-28.3%
10	RAPT	RAPT Therapeutics	7.0%	128.9%

1 Day Top Losers

#	Ticker	Company	1D Rtn	YTD Rtn
1	AIV	Apartment Investment & Management	-29.3%	-8.6%
2	LAC	Lithium Americas	-21.7%	148.8%
3	IIIN	Insteel Industries	-19.2%	12.6%
4	BITF	Bitfarms	-18.4%	254.4%
5	BKSY	BlackSky Technology	-17.6%	141.5%
6	EOSE	Eos Energy Enterprises	-15.5%	217.9%
7	USAR	USA Rare Earth	-15.3%	95671.8%
8	SLDP	Solid Power	-15.2%	219.6%
9	LAR	Lithium Argentina	-14.9%
10	RGTI	Rigetti Computing	-14.9%	214.4%

1 Week Top Gainers

#	Ticker	Company	1W Rtn	YTD Rtn
1	PRAX	Praxis Precision Medicines	197.1%	111.4%
2	NVTS	Navitas Semiconductor	95.4%	337.8%
3	MVST	Microvast	41.0%	209.2%
4	EXK	Endeavour Silver	33.7%	177.3%
5	BE	Bloom Energy	32.8%	418.2%
6	FLNC	Fluence Energy	31.4%	23.3%
7	BITF	Bitfarms	26.6%	254.4%
8	ASM	Avino Silver & Gold Mines	26.6%	635.5%
9	BTDR	Bitdeer Technologies	26.2%	19.4%
10	POWI	Power Integrations	25.4%	-22.8%

1 Week Top Losers

#	Ticker	Company	1W Rtn	YTD Rtn
1	BNT	Brookfield Wealth Solutions	-34.9%	15.4%
2	BN	Brookfield	-34.8%	15.5%
3	SOC	Sable Offshore	-33.2%	-42.7%
4	SRRK	Scholar Rock	-28.2%	-31.9%
5	ALAB	Astera Labs	-27.4%	23.5%
6	VG	Venture Global	-27.4%
7	AIV	Apartment Investment & Management	-27.0%	-8.6%
8	TLRY	Tilray Brands	-26.7%	15.8%
9	ONDS	Ondas	-21.8%	220.3%
10	BBBY	Bed Bath & Beyond	-21.6%

1 Month Top Gainers

#	Ticker	Company	1M Rtn	YTD Rtn
1	WOLF	Wolfspeed	1092.6%	387.1%
2	QURE	uniQure	323.7%	239.7%
3	PRAX	Praxis Precision Medicines	269.5%	111.4%
4	FLNC	Fluence Energy	163.2%	23.3%
5	NVTS	Navitas Semiconductor	142.0%	337.8%
6	SES	SES AI	141.5%	43.4%
7	CLPT	ClearPoint Neuro	137.1%	64.4%
8	LAC	Lithium Americas	126.7%	148.8%
9	GRAL	GRAIL	125.5%	384.1%
10	UAMY	United States Antimony	124.3%	609.6%

1 Month Top Losers

#	Ticker	Company	1M Rtn	YTD Rtn
1	SOC	Sable Offshore	-46.4%	-42.7%
2	FLY	Firefly Aerospace	-35.3%
3	VG	Venture Global	-34.5%
4	ALAB	Astera Labs	-34.4%	23.5%
5	LDI	loanDepot	-34.2%	47.1%
6	PGY	Pagaya Technologies	-34.0%	198.2%
7	OPEN	Opendoor Technologies	-30.4%	344.4%
8	USNA	Usana Health Sciences	-30.2%	-41.3%
9	UPST	Upstart	-29.9%	-22.4%
10	UP	Wheels Up Experience	-29.7%	-6.7%

Recent Active Movers

1 Day Top Gainers

#	Ticker	Company	1D Rtn	YTD Rtn
1	PRAX	Praxis Precision Medicines	183.7%	111.4%
2	JBHT	JB Hunt Transport Services	22.1%	0.3%
3	PSNL	Personalis	20.5%	77.9%
4	GRAL	GRAIL	14.4%	384.1%
5	GTLB	GitLab	10.6%	-14.3%
6	KYIV	Kyivstar	9.3%
7	HL	Hecla Mining	7.6%	211.0%
8	TFIN	Triumph Financial	7.1%	-43.6%
9	TFII	TFI International	7.1%	-28.3%
10	RAPT	RAPT Therapeutics	7.0%	128.9%

1 Day Top Losers

#	Ticker	Company	1D Rtn	YTD Rtn
1	AIV	Apartment Investment & Management	-29.3%	-8.6%
2	LAC	Lithium Americas	-21.7%	148.8%
3	IIIN	Insteel Industries	-19.2%	12.6%
4	BITF	Bitfarms	-18.4%	254.4%
5	BKSY	BlackSky Technology	-17.6%	141.5%
6	EOSE	Eos Energy Enterprises	-15.5%	217.9%
7	USAR	USA Rare Earth	-15.3%	95671.8%
8	SLDP	Solid Power	-15.2%	219.6%
9	LAR	Lithium Argentina	-14.9%
10	RGTI	Rigetti Computing	-14.9%	214.4%

1 Week Top Gainers

#	Ticker	Company	1W Rtn	YTD Rtn
1	PRAX	Praxis Precision Medicines	197.1%	111.4%
2	NVTS	Navitas Semiconductor	95.4%	337.8%
3	MVST	Microvast	41.0%	209.2%
4	EXK	Endeavour Silver	33.7%	177.3%
5	BE	Bloom Energy	32.8%	418.2%
6	FLNC	Fluence Energy	31.4%	23.3%
7	BITF	Bitfarms	26.6%	254.4%
8	ASM	Avino Silver & Gold Mines	26.6%	635.5%
9	BTDR	Bitdeer Technologies	26.2%	19.4%
10	POWI	Power Integrations	25.4%	-22.8%

1 Week Top Losers

#	Ticker	Company	1W Rtn	YTD Rtn
1	BNT	Brookfield Wealth Solutions	-34.9%	15.4%
2	BN	Brookfield	-34.8%	15.5%
3	SOC	Sable Offshore	-33.2%	-42.7%
4	SRRK	Scholar Rock	-28.2%	-31.9%
5	ALAB	Astera Labs	-27.4%	23.5%
6	VG	Venture Global	-27.4%
7	AIV	Apartment Investment & Management	-27.0%	-8.6%
8	TLRY	Tilray Brands	-26.7%	15.8%
9	ONDS	Ondas	-21.8%	220.3%
10	BBBY	Bed Bath & Beyond	-21.6%

Peer Comparisons for Owens & Minor

Financials

	OMI	MCK	CAH	HSIC	EMPG	COR	Median
Name	Owens & .	McKesson	Cardinal.	Henry Sc.	Empro	Cencora
Mkt Price	4.59	775.44	153.27	62.03	-	319.40	153.27
Mkt Cap	0.4	96.9	36.5	7.6	-	61.9	36.5
Rev LTM	8,731	377,595	222,578	12,773	-	316,654	222,578
Op Inc LTM	287	4,748	2,322	771	-	3,713	2,322
FCF LTM	-166	5,666	1,850	334	-	1,142	1,142
FCF 3Y Avg	130	4,463	2,488	436	-	2,588	2,488
CFO LTM	101	6,547	2,397	512	-	1,742	1,742
CFO 3Y Avg	353	5,194	3,001	619	-	3,101	3,001

Growth & Margins

	OMI	MCK	CAH	HSIC	EMPG	COR	Median
Name	Owens & .	McKesson	Cardinal.	Henry Sc.	Empro	Cencora
Rev Chg LTM	2.5%	20.3%	-1.9%	2.3%	-	11.6%	2.5%
Rev Chg 3Y Avg	-3.6%	12.2%	7.3%	0.2%	-	10.3%	7.3%
Rev Chg Q	3.3%	23.4%	0.5%	3.3%	-	8.7%	3.3%
QoQ Delta Rev Chg LTM	0.2%	5.2%	0.1%	0.8%	-	2.1%	0.8%
Op Mgn LTM	3.3%	1.3%	1.0%	6.0%	-	1.2%	1.3%
Op Mgn 3Y Avg	2.8%	1.4%	1.0%	5.8%	-	1.1%	1.4%
QoQ Delta Op Mgn LTM	0.1%	-0.1%	0.0%	-0.0%	-	0.0%	0.0%
CFO/Rev LTM	1.2%	1.7%	1.1%	4.0%	-	0.6%	1.2%
CFO/Rev 3Y Avg	3.7%	1.6%	1.4%	4.9%	-	1.1%	1.6%
FCF/Rev LTM	-1.9%	1.5%	0.8%	2.6%	-	0.4%	0.8%
FCF/Rev 3Y Avg	1.3%	1.4%	1.1%	3.5%	-	0.9%	1.3%

Valuation

	OMI	MCK	CAH	HSIC	EMPG	COR	Median
Name	Owens & .	McKesson	Cardinal.	Henry Sc.	Empro	Cencora
Mkt Cap	0.4	96.9	36.5	7.6	-	61.9	36.5
P/S	0.0	0.3	0.2	0.6	-	0.2	0.2
P/EBIT	-1.2	21.2	15.8	11.4	-	21.1	15.8
P/E	-0.3	30.6	23.4	19.4	-	32.6	23.4
P/CFO	3.5	14.8	15.2	14.8	-	35.5	14.8
Total Yield	-340.6%	3.6%	5.6%	5.1%	-	3.8%	3.8%
Dividend Yield	0.0%	0.4%	1.4%	0.0%	-	0.7%	0.4%
FCF Yield 3Y Avg	6.1%	6.1%	9.3%	4.8%	-	5.9%	6.1%
D/E	5.8	0.1	0.2	0.4	-	0.1	0.2
Net D/E	5.7	0.1	0.1	0.4	-	0.1	0.1

Returns

	OMI	MCK	CAH	HSIC	EMPG	COR	Median
Name	Owens & .	McKesson	Cardinal.	Henry Sc.	Empro	Cencora
1M Rtn	-7.5%	11.8%	3.6%	-9.3%	-	10.1%	3.6%
3M Rtn	-42.6%	9.3%	-3.6%	-10.7%	-	8.7%	-3.6%
6M Rtn	-33.8%	11.5%	14.5%	-4.2%	-	11.8%	11.5%
12M Rtn	-67.3%	52.4%	38.1%	-13.5%	-	36.1%	36.1%
3Y Rtn	-72.2%	121.8%	138.0%	-8.4%	-	131.7%	121.8%
1M Excs Rtn	-15.3%	11.6%	3.0%	-8.4%	-	10.1%	3.0%
3M Excs Rtn	-46.1%	4.1%	-8.9%	-15.5%	-	4.0%	-8.9%
6M Excs Rtn	-57.9%	-13.8%	-10.9%	-27.6%	-	-12.9%	-13.8%
12M Excs Rtn	-79.4%	39.8%	25.8%	-25.8%	-	30.1%	25.8%
3Y Excs Rtn	-164.9%	38.9%	46.1%	-93.5%	-	48.1%	38.9%

Financials

Annual
Quarterly

$ Mil \| FY: 12/31	LTM	2024	2023	2022	2021	2020	2019
Period End	6/30/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019
Filing Date	8/11/2025	2/28/2025	2/20/2024	2/28/2023	2/23/2022	2/24/2021	3/4/2020
Key Financials
Total Revenue	8,731	10,701	10,334	9,955	9,785	8,480	9,211
EBITDA	-54	51	391	368	415	287	186
Operating Income	287	296	305	277	442	242	103
Net Income	-1,203	-363	-41	22	222	30	-62
EPS	-15.63	-4.73	-0.54	0.30	3.05	0.47	-1.03
Growth Rates
Total Revenue Growth	2.5%	3.6%	3.8%	1.7%	15.4%	-7.9%	-2.2%
EBITDA Growth	-113.7%	-86.9%	6.0%	-11.3%	44.9%	54.0%	173.2%
Operating Income Growth	-3.9%	-2.8%	10.1%	-37.4%	82.9%	134.4%	-14.5%
Net Income Growth	-2734.3%	-778.2%	-284.5%	-89.9%	641.8%	147.9%	85.7%
Margins
EBITDA Margin	-0.6%	0.5%	3.8%	3.7%	4.2%	3.4%	2.0%
Operating Income Margin	3.3%	2.8%	2.9%	2.8%	4.5%	2.9%	1.1%
Net Income Margin	-13.8%	-3.4%	-0.4%	0.2%	2.3%	0.4%	-0.7%
Cash & Debt
Total Cash	38	49	243	69	56	83	67
Total Debt	2,059	2,140	2,320	2,716	1,110	1,106	1,625
Net Debt / (Cash)	2,020	2,090	2,077	2,647	1,054	1,023	1,558
Cash Flows
Net Cash from Operations	101	161	741	325	124	339	166
Free Cash from Operations	-166	-67	533	158	74	280	114
Returns to Shareholders
Dividends	0	-0	-0	-0	1	1	5
Share Repurchases	7	-0	-0	-0	-0	-0	-0

$ Mil \| FY: 12/31	2025Q2	2025Q1	2024Q4	2024Q3	2024Q2	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3
Period End	6/30/2025	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Filing Date	8/11/2025	5/8/2025	2/28/2025	11/4/2024	8/2/2024	5/3/2024	2/20/2024	11/3/2023	8/4/2023	5/5/2023	2/28/2023	11/2/2022
Key Financials Quarterly
Total Revenue	682	2,632	2,696	2,721	660	2,613	2,656	2,592	2,563	2,523	2,551	2,497
Ebitda	0	60	-199	84	80	83	129	101	82	79	19	118
Operating Income	57	61	95	74	46	57	111	84	62	48	-25	83
Net Income	-869	-25	-296	-13	-32	-22	18	-6	-28	-24	-58	12
EPS	-11.30	-0.32	-3.84	-0.17	-0.42	-0.29	0.23	-0.08	-0.37	-0.32	-0.77	0.17
Key Financials TTM
Total Revenue TTM	8,731	8,710	8,690	8,650	8,521	10,424	10,334	10,229	10,135	10,071	9,955	9,872
Ebitda TTM	-54	26	48	376	392	394	391	281	298	363	368	433
Operating Income TTM	287	276	273	288	298	314	305	169	168	220	277	417
Net Income TTM	-1,203	-366	-363	-49	-42	-39	-41	-117	-98	-41	22	122
Growth Rates Quarterly
Total Revenue Growth	3.3%	0.7%	1.5%	5.0%	-74.2%	3.6%	4.1%	3.8%	2.5%	4.8%	3.4%	-0.2%
EBITDA Growth	-99.4%	-27.3%	-254.6%	-16.3%	-2.3%	4.1%	578.0%	-14.3%	-44.5%	-6.0%	-77.3%	38.8%
Operating Income Growth	23.1%	6.4%	-14.3%	-11.9%	-25.6%	20.3%	541.0%	0.9%	-45.4%	-54.5%	-121.9%	20.5%
Net Income Growth	-2623.2%	-14.1%	-1765.1%	-98.7%	-13.0%	10.4%	130.7%	-151.4%	-198.7%	-162.2%	-238.2%	-71.7%
Margins Quarterly
EBITDA Margin	0.1%	2.3%	-7.4%	3.1%	12.1%	3.2%	4.8%	3.9%	3.2%	3.1%	0.7%	4.7%
Operating Income Margin	8.3%	2.3%	3.5%	2.7%	7.0%	2.2%	4.2%	3.3%	2.4%	1.9%	-1.0%	3.3%
Net Income Margin	-127.4%	-0.9%	-11.0%	-0.5%	-4.8%	-0.8%	0.7%	-0.2%	-1.1%	-1.0%	-2.3%	0.5%
Cash & Debt
Total Cash	38	59	49	45	244	245	243	215	286	67	69	77
Total Debt	2,059	2,271	2,140	2,173	2,380	2,430	2,320	2,339	2,525	2,571	2,716	2,762
Net Debt / (Cash)	2,020	2,212	2,090	2,128	2,137	2,185	2,077	2,124	2,238	2,504	2,647	2,685
Cash Flows Quarterly
FCF from Operations	38	-35	71	27	116	-53	112	157	313	158	87	69
Cash Flows TTM
FCF from Operations TTM	101	179	161	202	332	529	741	716	627	404	325	288
Returns to Shareholders Quarterly
Dividends	0	0	0	0	0	0	0	0	0	0	0	0
Share Repurchases	5	2	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0
Return on Invested Capital (ROIC) Quarterly
ROIC	8.6%	6.2%	14.2%	10.2%	4.9%	6.8%	14.3%	7.4%	8.1%	4.5%	-1.9%	6.7%
Return on Invested Capital (ROIC) TTM
ROIC TTM	10.6%	9.4%	9.9%	8.6%	7.2%	9.3%	8.7%	4.3%	4.2%	4.2%	8.7%	10.3%

Segment Financials

Revenue by Segment

$ Mil	2024	2023	2022	2021	2020
Products & Healthcare Services	7,781	7,898	8,826
Patient Direct	2,553	2,057	960
Global Products				1,810	1,434
Global Solutions				7,212	8,244
Inter-segment net revenue				-542	-467
Total	10,334	9,955	9,785	8,480	9,211

Operating Income by Segment

$ Mil	2024	2023	2022	2021	2020
Patient Direct	247	194	58
Products & Healthcare Services	58	175	384
Exit and realignment charges, net	-99	-7	-31
Acquisition-related charges and intangible amortization	-101	-127	-43
Inventory valuation adjustment		-92	0
Acquisition-related and exit and realignment charges				-38	-30
Global Products				260	65
Global Solutions				31	84
Intangible amortization				-41	-44
Inter-segment eliminations				-8	0
Other					-1
Total	105	143	368	204	73

Assets by Segment

$ Mil	2024	2021	2020
Patient Direct	2,490
Products & Healthcare Services	2,360
Cash and cash equivalents	243	83	67
Global Products		1,135	931
Global Solutions		2,117	2,205
Discontinued operations			440
Total	5,093	3,336	3,643

Price Behavior

Price Behavior

Market Price	$4.59
Market Cap ($ Bil)	0.4
First Trading Date	12/16/1988
Distance from 52W High	-69.5%
	50 Days	200 Days
DMA Price	$5.15	$7.92
DMA Trend	down	down
Distance from DMA	-10.9%	-42.0%
	3M	1YR
Volatility	98.4%	89.4%
Downside Capture	580.14	245.49
Upside Capture	106.47	98.87
Correlation (SPY)	24.0%	21.8%

OMI Betas & Captures as of 9/30/2025

	1M	2M	3M	6M	1Y	3Y
Beta	-0.92	3.41	3.30	0.71	1.03	1.38
Up Beta	2.28	5.31	4.62	-0.07	0.48	1.25
Down Beta	-4.18	-0.94	1.07	0.91	0.67	0.91
Up Capture	-76%	180%	84%	90%	114%	200%
Bmk +ve Days	13	23	35	74	144	420
Stock +ve Days	8	15	21	53	109	364
Down Capture	-102%	607%	569%	208%	158%	110%
Bmk -ve Days	8	19	29	52	107	330
Stock -ve Days	12	26	41	71	138	378

[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively

Short Interest

Short Interest: As Of Date	9302025
Short Interest: Shares Quantity	7,796,151
Short Interest: % Change Since 9152025	-21.6%
Average Daily Volume	3,540,815
Days-to-Cover Short Interest	2.20
Basic Shares Quantity	76,935,000
Short % of Basic Shares	10.1%

Returns Analyses

	Title
0	With Owens & Minor Stock Down 14% In A Month, How Confident Are You?
1	Owens & Minor Stock Return Comparison
2	[10/15/2021] Owens & Minor (OMI) Stock Price Forecast: AI Forecasts OMI Stock Price To Be Around $33.80 In A Month (Up 2.5%)
3	Owens & Minor (OMI) Stock Return: AI Predicts OMI Average and Excess Return After a Fall or Rise

Earnings Returns History

Expand for More

	Forward Returns
Earnings Date	1D Returns	5D Returns	21D Returns
8/11/2025	-34.7%	-19.9%	-22.0%
5/8/2025	-9.9%	-9.8%	3.2%
2/3/2025	-35.2%	-39.3%	-31.8%
11/4/2024	-10.2%	-3.4%	7.3%
7/23/2024	7.6%	0.8%	2.1%
5/3/2024	-25.7%	-25.0%	-28.5%
2/20/2024	1.6%	11.6%	19.1%
11/3/2023	27.1%	13.7%	46.3%
...
SUMMARY STATS
# Positive	8	8	12
# Negative	13	13	9
Median Positive	7.2%	12.7%	13.7%
Median Negative	-11.5%	-17.4%	-20.5%
Max Positive	29.2%	29.8%	46.3%
Max Negative	-35.2%	-39.3%	-33.7%

	Forward Returns
8/11/2025	-34.7%	-19.9%	-22.0%
5/8/2025	-9.9%	-9.8%	3.2%
2/3/2025	-35.2%	-39.3%	-31.8%
11/4/2024	-10.2%	-3.4%	7.3%
7/23/2024	7.6%	0.8%	2.1%
5/3/2024	-25.7%	-25.0%	-28.5%
2/20/2024	1.6%	11.6%	19.1%
11/3/2023	27.1%	13.7%	46.3%
8/4/2023	1.3%	7.6%	-6.8%
2/28/2023	-21.8%	-20.9%	-33.7%
10/12/2022	-35.0%	-28.2%	-20.3%
8/3/2022	-11.5%	-9.2%	-19.5%
2/23/2022	6.7%	18.4%	17.8%
11/3/2021	22.3%	15.9%	8.9%
8/3/2021	-8.8%	-17.4%	-20.5%
5/5/2021	-8.0%	-3.9%	21.4%
2/24/2021	29.2%	29.8%	36.0%
11/2/2020	-2.3%	-13.7%	-3.5%
8/4/2020	-14.3%	-10.8%	4.2%
3/4/2020	-10.5%	-27.6%	19.2%
11/6/2019	1.6%	4.0%	9.6%
SUMMARY STATS
# Positive	8	8	12
# Negative	13	13	9
Median Positive	7.2%	12.7%	13.7%
Median Negative	-11.5%	-17.4%	-20.5%
Max Positive	29.2%	29.8%	46.3%
Max Negative	-35.2%	-39.3%	-33.7%

SEC Filings

Expand for More

Report Date	Filing Date	Filing
6302025	8112025	10-Q 6/30/2025
3312025	5082025	10-Q 3/31/2025
12312024	2282025	10-K 12/31/2024
9302024	11042024	10-Q 9/30/2024
6302024	8022024	10-Q 6/30/2024
3312024	5032024	10-Q 3/31/2024
12312023	2202024	10-K 12/31/2023
9302023	11032023	10-Q 9/30/2023
6302023	8042023	10-Q 6/30/2023
3312023	5052023	10-Q 3/31/2023
12312022	2282023	10-K 12/31/2022
9302022	11022022	10-Q 9/30/2022
6302022	8032022	10-Q 6/30/2022
3312022	5042022	10-Q 3/31/2022
12312021	2232022	10-K 12/31/2021
9302021	11032021	10-Q 9/30/2021

Insider Activity

Expand for More

Industry Resources

Health Care Resources

U.S. National Library of Medicine

Health Data Management

FDA Tracker

External Quote Links

0	Y Finance	Barrons
1	TradingView	Morningstar
2	SeekingAlpha	ValueLine
3	Motley Fool	Robinhood
4	CNBC	Etrade
5	MarketWatch	Unusual Whales
6	YCharts	Perplexity Finance
7	FinViz

Prefer one of these to Trefis? Tell us why.

Owens & Minor (OMI)

Market Price (10/17/2025): $4.58 | Market Cap: $352.4 MilSector: Health Care | Industry: Health Care Distributors

Owens & Minor (OMI)

Market Price (10/17/2025): $4.58Market Cap: $352.4 MilSector: Health CareIndustry: Health Care Distributors

Investment Highlights

Market Valuation & Key Metrics

OMI Stock

Return vs. Risk

Price Returns Compared

Downturns Compared

How Low Can It Go?

Preserve Wealth

Asset Allocation

Interactive Breakdown

Better Bets than Owens & Minor (OMI)

Latest Trefis Analyses

Trade Ideas

Recent Active Movers

1 Day Top Gainers

1 Day Top Losers

1 Week Top Gainers

1 Week Top Losers

1 Month Top Gainers

1 Month Top Losers

Recent Active Movers

1 Day Top Gainers

1 Day Top Losers

1 Week Top Gainers

1 Week Top Losers

More From Trefis

Research & Analysis

Invest in Strategies

Wealth Management

Peer Comparisons for Owens & Minor

Financials

Growth & Margins

Valuation

Returns

Comparison Analyses

FDIC Bank Data

Bank Capital

Bank Deposits

Bank Assets

Bank Loans

Financials

Segment Financials

Price Behavior

Short Interest

Returns Analyses

Earnings Returns History

SEC Filings

Insider Activity

Industry Resources

External Quote Links

Market Price (10/17/2025): $4.58 | Market Cap: $352.4 Mil
Sector: Health Care | Industry: Health Care Distributors

Market Price (10/17/2025): $4.58
Market Cap: $352.4 Mil
Sector: Health Care
Industry: Health Care Distributors